Sphere Fluidics

37 articles about Sphere Fluidics

• Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

  10/3/2023

  Sphere Fluidics announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world leading end-to-end antibody partner, providing integrated services across antibody discovery, engineering, and production, to expand its cell line development capabilities.

• Sphere Fluidics Updates Brand Identity to Align With Ambitious, Global Commercial Growth Strategy

  5/23/2023

  Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced the introduction of new branding to align with its ambitious global commercial growth strategy.

• Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors

  5/2/2023

  Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced that it has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors.

• Sphere Fluidics Begins Work With Partners on 3DSecret Program to Investigate Mechanisms of Metastasis in Cancer

  4/24/2023

  Sphere Fluidics announced its involvement in 3DSecret, a four-year research project funded through the European Innovation Council’s Pathfinder Open 2022, established under Horizon Europe, the EU’s key funding program for research and innovation.

• Sphere Fluidics Appoints Richard Hammond as Chief Technical Officer

  12/13/2022

  Sphere Fluidics announced that it has appointed Richard Hammond as Chief Technical Officer.

• Sphere Fluidics Opens New Laboratory Facilities at Granta Park in Cambridgeshire, UK

  10/25/2022

  Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced that it has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the Company’s growth.

• Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires

  5/10/2022

  Sphere Fluidics announced today that it has appointed three new hires to its commercial team.

• Sphere Fluidics Closes a $40 Million Funding Round Led by Sofinnova Partners and Redmile Group

  10/28/2021

  Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced that it has closed a $40 million investment round.

• 

  Global Roundup: Sigrid Therapeutics Forges Manufacturing Agreement with Japan's AGC

  6/10/2021

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• Sphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit

  6/7/2021

  Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, announced the launch of the biocompatible CYTRIX Microfluidic Hydrogel Kit.

• 

  Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase III Study

  5/20/2021

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  BioSpace Global Roundup, July 23

  7/23/2020

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

• Sphere Fluidics and Heriot-Watt University Collaborate to Develop Next Generation Droplet Generator Instrumentation

  7/20/2020

  Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, announced they have been awarded a Knowledge Transfer Partnership grant from Innovate UK, the UK’s innovation agency.

• 

  BioSpace Global Roundup, April 23

  4/23/2020

  Biopharma and life sciences groups from across the globe provide updates on their business and pipelines.

• Sphere Fluidics Receives Queen’s Award for Enterprise

  4/21/2020

  Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation

• Sphere Fluidics Expands Commercial Operations to Increase Supply of Pico-Surf Surfactant for Droplet Microfluidics

  2/13/2020

  Sphere Fluidics announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf™, for reliable and highly stable droplet generation and processing.

• 

  BioSpace Global Roundup, Nov. 7

  11/7/2019

  Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines.

• Sphere Fluidics and Peak Analysis and Automation Introduce Integrated Micro-plate Handling and Single Cell Analysis Capabilities

  11/5/2019

  Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development

• Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

  9/9/2019

  Sphere Fluidics introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.

• 

  BioSpace Global Roundup, Aug. 22

  8/22/2019

  Companies from across the globe provide updates on their business and pipelines.